Chepstow based Creo Medical is bringing advanced energy to therapeutic endoscopy through the development and commercialisation of a suite of minimally invasive medical devices. Its CROMA platform delivers a combination of advanced bi-polar radiofrequency (RF) and microwave energy for the purpose of dissection, resection, ablation and haemostasis of diseased tissue. The initial focus is on gastrointestinal (GI) procedures expanding into soft tissues (such as the pancreas) and pulmonology. Creo’s first commercially available CROMA compatible device, Speedboat Inject, is in everyday use across the globe and was recently added to the NHS Wales framework.

Creo now also have offices in Singapore, the US and across Europe as they bring their multi-patented portfolio to new markets.